LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged eu · clear

Trademark

Is Brexit an IP Exit?

Summary Voters in the U.K. recently passed a referendum paving the way for the U.K. to leave the European Union (EU). In response, British Prime Minister David Cameron resigned on Wednesday, July 13, 2016, with Theresa May as his successor. These events…

August 12, 2016·Trademark·4 min read
Unsorted

Finally, a unified EU patent

Early this week the European Union finally accomplished what has long seemed highly unlikely--a unified European Patent known as the "unitary" patent. Designed to address Europe's lagging role in the innovation world, the unitary patent…

December 13, 2012·Unsorted·4 min read
Unsorted

Analysis: EU patent ruling threatens global stem cell research

In a recent decision, the European Union Court of Justice, sitting in Grand Chamber, has ruled on three questions concerning interpretation of Article 6(2)(c) of EU Directive 98/44/EC on legal protection of biotechnological inventions: 1) What is meant by…

October 25, 2011·Unsorted·3 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.